Home Solutions Cardiac Solutions ECG — On-site to DCT and Phase I-IV

ECG — On-site to DCT and Phase I-IV

Monitor every heartbeat with precision from anywhere to ensure safety throughout your site-based or decentralized clinical trial.

Cardiac safety issues are a key driver in drug development delays and abandonment.

Talk to a specialist

Cardiac safety concerns are among the leading reasons that promising drugs are delayed or abandoned. Centralized ECG collection drives optimal enrollment decisions, increases patient safety and speeds trials. Clario is a leading provider of ECG services, with 50 years of experience designing and conducting successful studies. We offer a range of options tailored to your compound, site locations and ever-changing regulatory requirements.

Product detail

Our solution empowers studies with standard assessments, high-quality data and centralized monitoring to minimize risk. Whether using a traditional ECG collection model or looking for a way to virtualize your clinical trial, our solution can be customized to support your trial design.

Traditional ECG

Relying on site local ECG collection causes inconsistency, poor-quality data can result in erroneously including/excluding patients due to inaccurate machine measurements
Our consistent equipment and analysis methodology specifically designed for clinical trials equates to high quality, clean, consistent, digital ECG data, delivered centrally to the client

Home ECG

Simple easy-to-use design enables patient-administered ECGs at home
Our solution is fully integrated with Clario’s platform and enables clinical-trial-quality centralized ECG reads
Flexible technology supports patients or traveling nurse collection models with all the same benefits of a traditional site-based ECG
Clario applies operational expertise enabling our sponsors to execute trials in the most challenging and ever-evolving environments